The pharmaceutical supply chain is experiencing unprecedented disruptions, with patients facing extended waiting periods for essential medications. Healthcare systems are grappling with critical shortages affecting multiple drug categories, forcing individuals to adopt dangerous coping strategies such as medication rationing and tablet splitting. This crisis, described as the most severe in four decades, poses significant risks to public health outcomes and medication efficacy. Regulatory bodies and pharmaceutical distributors are working to address the systemic challenges contributing to these widespread inventory failures.

Summary auto-generated by AI from the original publisher's content. Editorial standards.